Guidelines on the use of extracorporeal photopheresis

R Knobler; G Berlin; P Calzavara-Pinton; H Greinix; P Jaksch; L Laroche; J Ludvigsson; P Quaglino; W Reinisch; J Scarisbrick; Thomas Benzion Schwarz; P Wolf; P Arenberger; Chalid Assaf; M Bagot; M Barr; A Bohbot; L Bruckner-Tuderman; B Dreno; A Enk; L French; R Gniadecki; H Gollnick; M Hertl; C Jantschitsch; A Jung; U Just; C-D Klemke; U Lippert; T Luger; E Papadavid; H Pehamberger; Annamari Ranki; Robert Stadler; W Sterry; Inga Wolf; M Worm; J Zic; C C Zouboulis; U Hillen

doi:10.1111/jdv.12311

Guidelines on the use of extracorporeal photopheresis

R Knobler
, G Berlin
, P Calzavara-Pinton
, H Greinix
, P Jaksch
, L Laroche
, J Ludvigsson
, P Quaglino
, W Reinisch
, J Scarisbrick
, Thomas Benzion Schwarz
, P Wolf
, P Arenberger
, Chalid Assaf
, M Bagot
, M Barr
, A Bohbot
, L Bruckner-Tuderman
, B Dreno
, A Enk

L French, R Gniadecki, H Gollnick, M Hertl, C Jantschitsch, A Jung, U Just, C-D Klemke, U Lippert, T Luger, E Papadavid, H Pehamberger, Annamari Ranki, Robert Stadler, W Sterry, Inga Wolf, M Worm, J Zic, C C Zouboulis, U Hillen

Department of Dermatology

189 Citations (Scopus)

Abstract

BACKGROUND: After the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma was published in 1983 with its subsequent recognition by the FDA for its refractory forms, the technology has shown significant promise in the treatment of other severe and refractory conditions in a multi-disciplinary setting. Among the major studied conditions are graft versus host disease after allogeneic bone marrow transplantation, systemic sclerosis, solid organ transplant rejection and inflammatory bowel disease.

MATERIALS AND METHODS: In order to provide recognized expert practical guidelines for the use of this technology for all indications the European Dermatology Forum (EDF) proceeded to address these questions in the hands of the recognized experts within and outside the field of dermatology. This was done using the recognized and approved guidelines of EDF for this task.

RESULTS AND CONCLUSION: These guidelines provide at present the most comprehensive available expert recommendations for the use of extracorporeal photopheresis based on the available published literature and expert consensus opinion.

Original language	English
Journal	Journal of the European Academy of Dermatology and Venereology : JEADV
Volume	28 Suppl 1
Pages (from-to)	1-37
Number of pages	37
ISSN	0926-9959
DOIs	https://doi.org/10.1111/jdv.12311
Publication status	Published - Jan 2014

Keywords

Autoimmune Diseases
Graft Rejection
Graft vs Host Disease
Humans
Inflammatory Bowel Diseases
Lymphoma, T-Cell, Cutaneous
Photopheresis
Photosensitizing Agents
Scleroderma, Systemic
Skin Neoplasms
Treatment Outcome

Access to Document

10.1111/jdv.12311

Cite this

Knobler, R., Berlin, G., Calzavara-Pinton, P., Greinix, H., Jaksch, P., Laroche, L., Ludvigsson, J., Quaglino, P., Reinisch, W., Scarisbrick, J., Schwarz, T. B., Wolf, P., Arenberger, P., Assaf, C., Bagot, M., Barr, M., Bohbot, A., Bruckner-Tuderman, L., Dreno, B., ... Hillen, U. (2014). Guidelines on the use of extracorporeal photopheresis. Journal of the European Academy of Dermatology and Venereology : JEADV, 28 Suppl 1, 1-37. https://doi.org/10.1111/jdv.12311

Knobler, R, Berlin, G, Calzavara-Pinton, P, Greinix, H, Jaksch, P, Laroche, L, Ludvigsson, J, Quaglino, P, Reinisch, W, Scarisbrick, J, Schwarz, TB, Wolf, P, Arenberger, P, Assaf, C, Bagot, M, Barr, M, Bohbot, A, Bruckner-Tuderman, L, Dreno, B, Enk, A, French, L, Gniadecki, R, Gollnick, H, Hertl, M, Jantschitsch, C, Jung, A, Just, U, Klemke, C-D, Lippert, U, Luger, T, Papadavid, E, Pehamberger, H, Ranki, A, Stadler, R, Sterry, W, Wolf, I, Worm, M, Zic, J, Zouboulis, CC & Hillen, U 2014, 'Guidelines on the use of extracorporeal photopheresis', Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 28 Suppl 1, pp. 1-37. https://doi.org/10.1111/jdv.12311

@article{3cee4e4528084cc6986e9fabc6e7e83c,

title = "Guidelines on the use of extracorporeal photopheresis",

abstract = "BACKGROUND: After the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma was published in 1983 with its subsequent recognition by the FDA for its refractory forms, the technology has shown significant promise in the treatment of other severe and refractory conditions in a multi-disciplinary setting. Among the major studied conditions are graft versus host disease after allogeneic bone marrow transplantation, systemic sclerosis, solid organ transplant rejection and inflammatory bowel disease.MATERIALS AND METHODS: In order to provide recognized expert practical guidelines for the use of this technology for all indications the European Dermatology Forum (EDF) proceeded to address these questions in the hands of the recognized experts within and outside the field of dermatology. This was done using the recognized and approved guidelines of EDF for this task.RESULTS AND CONCLUSION: These guidelines provide at present the most comprehensive available expert recommendations for the use of extracorporeal photopheresis based on the available published literature and expert consensus opinion.",

keywords = "Autoimmune Diseases, Graft Rejection, Graft vs Host Disease, Humans, Inflammatory Bowel Diseases, Lymphoma, T-Cell, Cutaneous, Photopheresis, Photosensitizing Agents, Scleroderma, Systemic, Skin Neoplasms, Treatment Outcome",

author = "R Knobler and G Berlin and P Calzavara-Pinton and H Greinix and P Jaksch and L Laroche and J Ludvigsson and P Quaglino and W Reinisch and J Scarisbrick and Schwarz, \{Thomas Benzion\} and P Wolf and P Arenberger and Chalid Assaf and M Bagot and M Barr and A Bohbot and L Bruckner-Tuderman and B Dreno and A Enk and L French and R Gniadecki and H Gollnick and M Hertl and C Jantschitsch and A Jung and U Just and C-D Klemke and U Lippert and T Luger and E Papadavid and H Pehamberger and Annamari Ranki and Robert Stadler and W Sterry and Inga Wolf and M Worm and J Zic and Zouboulis, \{C C\} and U Hillen",

note = "{\textcopyright} 2013 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley \& Sons Ltd on behalf of European Academy of Dermatology and Venereology.",

year = "2014",

month = jan,

doi = "10.1111/jdv.12311",

language = "English",

volume = "28 Suppl 1",

pages = "1--37",

journal = "Journal of the European Academy of Dermatology and Venereology : JEADV",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Guidelines on the use of extracorporeal photopheresis

AU - Knobler, R

AU - Berlin, G

AU - Calzavara-Pinton, P

AU - Greinix, H

AU - Jaksch, P

AU - Laroche, L

AU - Ludvigsson, J

AU - Quaglino, P

AU - Reinisch, W

AU - Scarisbrick, J

AU - Schwarz, Thomas Benzion

AU - Wolf, P

AU - Arenberger, P

AU - Assaf, Chalid

AU - Bagot, M

AU - Barr, M

AU - Bohbot, A

AU - Bruckner-Tuderman, L

AU - Dreno, B

AU - Enk, A

AU - French, L

AU - Gniadecki, R

AU - Gollnick, H

AU - Hertl, M

AU - Jantschitsch, C

AU - Jung, A

AU - Just, U

AU - Klemke, C-D

AU - Lippert, U

AU - Luger, T

AU - Papadavid, E

AU - Pehamberger, H

AU - Ranki, Annamari

AU - Stadler, Robert

AU - Sterry, W

AU - Wolf, Inga

AU - Worm, M

AU - Zic, J

AU - Zouboulis, C C

AU - Hillen, U

PY - 2014/1

Y1 - 2014/1

N2 - BACKGROUND: After the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma was published in 1983 with its subsequent recognition by the FDA for its refractory forms, the technology has shown significant promise in the treatment of other severe and refractory conditions in a multi-disciplinary setting. Among the major studied conditions are graft versus host disease after allogeneic bone marrow transplantation, systemic sclerosis, solid organ transplant rejection and inflammatory bowel disease.MATERIALS AND METHODS: In order to provide recognized expert practical guidelines for the use of this technology for all indications the European Dermatology Forum (EDF) proceeded to address these questions in the hands of the recognized experts within and outside the field of dermatology. This was done using the recognized and approved guidelines of EDF for this task.RESULTS AND CONCLUSION: These guidelines provide at present the most comprehensive available expert recommendations for the use of extracorporeal photopheresis based on the available published literature and expert consensus opinion.

AB - BACKGROUND: After the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma was published in 1983 with its subsequent recognition by the FDA for its refractory forms, the technology has shown significant promise in the treatment of other severe and refractory conditions in a multi-disciplinary setting. Among the major studied conditions are graft versus host disease after allogeneic bone marrow transplantation, systemic sclerosis, solid organ transplant rejection and inflammatory bowel disease.MATERIALS AND METHODS: In order to provide recognized expert practical guidelines for the use of this technology for all indications the European Dermatology Forum (EDF) proceeded to address these questions in the hands of the recognized experts within and outside the field of dermatology. This was done using the recognized and approved guidelines of EDF for this task.RESULTS AND CONCLUSION: These guidelines provide at present the most comprehensive available expert recommendations for the use of extracorporeal photopheresis based on the available published literature and expert consensus opinion.

KW - Autoimmune Diseases

KW - Graft Rejection

KW - Graft vs Host Disease

KW - Humans

KW - Inflammatory Bowel Diseases

KW - Lymphoma, T-Cell, Cutaneous

KW - Photopheresis

KW - Photosensitizing Agents

KW - Scleroderma, Systemic

KW - Skin Neoplasms

KW - Treatment Outcome

U2 - 10.1111/jdv.12311

DO - 10.1111/jdv.12311

M3 - Journal article

C2 - 24354653

SN - 0926-9959

VL - 28 Suppl 1

SP - 1

EP - 37

JO - Journal of the European Academy of Dermatology and Venereology : JEADV

JF - Journal of the European Academy of Dermatology and Venereology : JEADV

ER -

Guidelines on the use of extracorporeal photopheresis

Abstract

Keywords

Access to Document

Fingerprint

Cite this